高磷血症-话题@MedSci

#高磷血症#

8篇内容 | 1291人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2233253, encodeId=ed102233253fe, content=<a href='/topic/show?id=bfe710950042' target=_blank style='color:#2F92EE;'>#终末期肾病（ESRD）#</a> <a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Tenapanor在终末期肾病患者高磷血症中的疗效和安全性, objectType=article, longId=848600, objectId=c0f9848600c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401025/1729867551697_5121051.png, objectUrl=/article/show_article.do?id=c0f9848600c8, replyNumber=0, likeNumber=22, createdTime=2024-10-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c0f9848600c8, moduleTitle=Tenapanor在终末期肾病患者高磷血症中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f9848600c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196901, encodeId=92e82196901cd, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a> <a href='/topic/show?id=552311305e14' target=_blank style='color:#2F92EE;'>#钠/氢交换体3 (NHE3)的选择性抑制剂#</a>, objectTitle=Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性, objectType=article, longId=820198, objectId=c828820198b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697149625181_4754896.jpeg, objectUrl=/article/show_article.do?id=c828820198b2, replyNumber=0, likeNumber=136, createdTime=2024-04-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c828820198b2, moduleTitle=Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c828820198b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1662835, encodeId=f1bd1662835c5, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择, objectType=article, longId=219666, objectId=256921966684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=256921966684, replyNumber=0, likeNumber=72, createdTime=2022-04-28, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=256921966684, moduleTitle=新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=256921966684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662834, encodeId=a34f166283496, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响, objectType=article, longId=211559, objectId=a814211559f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a814211559f9, replyNumber=0, likeNumber=140, createdTime=2022-04-11, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a814211559f9, moduleTitle=JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a814211559f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662833, encodeId=8b3e166283386, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, objectType=article, longId=202181, objectId=a7c6202181f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7c6202181f3, replyNumber=0, likeNumber=118, createdTime=2021-07-23, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7c6202181f3, moduleTitle=高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7c6202181f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662832, encodeId=35151662832dd, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , objectType=article, longId=200106, objectId=c2aa200106d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2aa200106d4, replyNumber=0, likeNumber=146, createdTime=2021-05-02, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2aa200106d4, moduleTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2aa200106d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662831, encodeId=043b1662831ba, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标, objectType=article, longId=184167, objectId=053a18416e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=053a18416e94, replyNumber=0, likeNumber=122, createdTime=2020-01-26, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=053a18416e94, moduleTitle=Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=053a18416e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662830, encodeId=247216628303a, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点, objectType=article, longId=178809, objectId=55521e880970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55521e880970, replyNumber=0, likeNumber=141, createdTime=2020-02-15, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55521e880970, moduleTitle=Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55521e880970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662829, encodeId=af6216628298a, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症, objectType=article, longId=27431, objectId=90d32e4316f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90d32e4316f, replyNumber=0, likeNumber=133, createdTime=2014-07-13, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90d32e4316f, moduleTitle=FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90d32e4316f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1662828, encodeId=60e116628289c, content=<a href='/topic/show?id=27491025330f' target=_blank style='color:#2F92EE;'>#高磷血症#</a>, objectTitle=高频血透可有效控制高磷血症, objectType=article, longId=5129, objectId=4298512991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4298512991, replyNumber=0, likeNumber=162, createdTime=2013-02-04, rootId=0, userName=12498877m106暂无昵称, userId=2c4725514725, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4298512991, moduleTitle=高频血透可有效控制高磷血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4298512991)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高磷血症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#终末期肾病（ESRD）# #高磷血症#

Tenapanor在终末期肾病患者高磷血症中的疗效和安全性

2024-10-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#高磷血症# #钠/氢交换体3 (NHE3)的选择性抑制剂#

Clin Exp Nephrol：Tenapanor治疗日本腹膜透析患者高磷血症的疗效与安全性

2024-04-04发表于上海

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

新型磷结合剂「碳酸司维拉姆」在华获批又一适应证，为非透析慢性肾脏病高磷血症人群提供治疗新选择

2022-04-28

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

JAMA：碳酸镧 vs 碳酸钙对高磷血症患者血管钙化相关心血管事件风险的影响

2022-04-11

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

高磷血症药！百美特生物「醋酸钙片」首家通过一致性评价

2021-07-23

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关

2021-05-02

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Ardelyx的实验性药物Tenapanor达到了高磷血症的第二个III期研究的主要目标

2020-01-26

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

Ardelyx的钠/氢交换异构体抑制剂tenapanor符合高磷血症的III期研究的主要终点

2020-02-15

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

FDA批准Velphoro治疗慢性肾脏病透析患者高磷血症

2014-07-13

12498877m106暂无昵称 (审核中...)

前往app查看评论内容

#高磷血症#

高频血透可有效控制高磷血症

2013-02-04

科室
- - 订阅+
  - 更多科室
工具
服务